BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25639319)

  • 1. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
    Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
    Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
    Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
    Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas.
    Tani Y; Inoshita N; Sugiyama T; Kato M; Yamada S; Shichiri M; Hirata Y
    Eur J Endocrinol; 2010 Oct; 163(4):523-9. PubMed ID: 20616110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent gain-of-function USP8 mutations in Cushing's disease.
    Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
    Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.
    Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ
    Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
    Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV
    Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
    Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of neurogenins and NeuroD1 in human pituitary tumours.
    Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML
    J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling.
    Ren J; Jian F; Jiang H; Sun Y; Pan S; Gu C; Chen X; Wang W; Ning G; Bian L; Sun Q
    Int J Oncol; 2018 Jun; 52(6):1934-1946. PubMed ID: 29620167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles.
    Cassarino MF; Ambrogio AG; Cassarino A; Terreni MR; Gentilini D; Sesta A; Cavagnini F; Losa M; Pecori Giraldi F
    J Neuroendocrinol; 2018 Sep; 30(9):e12628. PubMed ID: 29920815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.
    Gentilin E; Tagliati F; Filieri C; Molè D; Minoia M; Rosaria Ambrosio M; Degli Uberti EC; Zatelli MC
    Endocrinology; 2013 May; 154(5):1690-700. PubMed ID: 23525216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
    Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
    Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
    Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
    Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
    Zhou YZ; Li CZ; Gao H; Zhang YZ
    World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
    Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
    Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
    Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
    Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.